Stock of the Day

November 12, 2021

RenaissanceRe (RNR)

$327.62
-$3.12 (-0.9%)
Market Cap: $13.74B

About RenaissanceRe

RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. It distributes products and services primarily through intermediaries. The company invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.

Today's Trend

RenaissanceRe Holdings Ltd. (NYSE: RNR) shares were modestly higher as investors weighed mixed earnings-estimate revisions from Zacks Research. The changes suggest stronger expectations for some near-term periods but modestly weaker forecasts across several later quarters and fiscal years.

  • Zacks raised its Q3 2026 EPS estimate to $5.93 from $4.77 and increased its FY2026 forecast to $41.20 from $38.39. The firm also lifted its Q3 2027 estimate to $6.89 from $5.51, providing a near-term earnings boost for RenaissanceRe.
  • The revised FY2026 estimate of $41.20 remains close to the current analyst consensus of $41.94 per share. Zacks also projects FY2027 EPS of $39.40 and FY2028 EPS of $43.77, indicating continued profitability but limited visibility on earnings growth.
  • Zacks reduced estimates for Q4 2026 EPS to $8.59 from $8.87, Q1 2027 to $10.69 from $11.15, and Q2 2027 to $12.06 from $12.77. It also cut FY2027 EPS to $39.40 from $39.94, Q4 2027 to $9.75 from $10.52, Q1 2028 to $11.99 from $12.19, Q2 2028 to $13.29 from $14.17, and FY2028 to $43.77 from $44.01.

Overall, the revisions are mixed: upgrades to Q3 2026 and full-year 2026 expectations may be supporting the stock, while the broader reductions to 2027 and 2028 forecasts temper the outlook. RenaissanceRe’s recent profitability—supported by a reported $12.92 quarterly EPS, $2.77 billion in revenue, and a 23.1% return on equity—provides a favorable fundamental backdrop, but investors may focus on whether future catastrophe losses or insurance-market conditions pressure earnings.

← Previous Stock of the DayNext Stock of the Day →